- Low-carbohydrate Diet and Low-Density Lipoprotein – Cholesterol (LDL-c) Interindividual Variability — Recruiting • Non-phase study • Oncology • NCT07675603.
- What is being tested: The trial investigates how individual patients respond differently to low-carbohydrate (ketogenic) diets in terms of LDL-cholesterol changes, recognising that the same dietary intervention produces variable lipid outcomes between individuals.
- Patient eligibility overview: The study enrolls adults without drug-resistant epilepsy who are suitable for ketogenic diet intervention, examining the metabolic and genetic factors that explain why some individuals experience beneficial versus unfavourable LDL-cholesterol responses.
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
Ketogenic diets are very low-carbohydrate diets that increase hepatic production of ketone bodies, which have several effects as substrates and signals. Ketogenic diets are used to manage some conditions (e.g., drug-resistant epilepsy), and their potential for managing many other conditions (e.g., cancer) is being actively explored. Indeed, the British Dietetic Association acknowledge the potential for ketogenic diets to improve glycaemic control to a greater extent than some other diets in people with type 2 diabetes. A lower fasting glucose is also relevant to future mortality in people without diabetes. Ketogenic…
- : * Age: >18 years * Body mass index: 18.5-35 kg·m-2 * Low-Density Lipoprotein-cholesterol 5.4 mmol/L) * dietary intolerances or allergies or to other study procedures * diagnosis of gastrointestinal disorders * any other condition/medication that could introduce bias to the study * already following a ketogenic diet * not willing to follow a ketogenic diet * unable to understand English language
Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.